JG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of ARQT stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Arcutis Biotherapeutics, Inc. (ARQT) stock worth $1K-$15K in a STOCK Act filing on Jul 22, 2022.
The trade happened on Jun 15, 2022, 37 days before it was made public.
ARQT has moved +51.8% since the trade date, from $20.55 to $31.20 (Oct 23, 2026 close).
- Traded
- Jun 15, 2022
- Disclosed
- Jul 22, 2022
- Filing delay
- 37 days
- Price since
- +51.8%
- Source
- STOCK Act disclosure
Other trades in this disclosure (33)
- SellSBUX$15K-$50KJul 22, 2022
- SellAAPL$1K-$15KJul 22, 2022
- SellAVNT$1K-$15KJul 22, 2022
- SellCOF$1K-$15KJul 22, 2022
- SellDE$1K-$15KJul 22, 2022
- SellDEO$1K-$15KJul 22, 2022
- SellDEO$1K-$15KJul 22, 2022
- SellEFX$1K-$15KJul 22, 2022
- SellFIS$1K-$15KJul 22, 2022
- SellHCA$1K-$15KJul 22, 2022
- SellINTU$1K-$15KJul 22, 2022
- BuyITT$1K-$15KJul 22, 2022
- SellLHCG$1K-$15KJul 22, 2022
- BuyMFC$1K-$15KJul 22, 2022
- SellMSFT$1K-$15KJul 22, 2022
- SellNSRGY$1K-$15KJul 22, 2022
- SellNSRGY$1K-$15KJul 22, 2022
- SellNTDOY$1K-$15KJul 22, 2022
- SellORCL$1K-$15KJul 22, 2022
- SellORCL$1K-$15KJul 22, 2022
More ARQT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.